- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Anti-PD-1 Antibody industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
3SBio Inc
Bio X Cell
Novartis
Thermo Fisher
Merck
Abbvie
Abcam
Lilly
InvivoGen
Ono Pharmaceutical Co, Ltd
BeiGene
Chugai Pharmaceutical Co, Ltd
Sino Biological Inc
BioVision Inc
TG Therapeutics, Inc
Arcus Biosciences
Bristol-Myers Squibb (BMS)
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Monoclonal
Polyclonal
Application:
IHC-P
ICC/IF
WB
Flow Cytometry
ELISA
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Anti-PD-1 Antibody Industry Overview
-
1.1.1 Anti-PD-1 Antibody Market Scope and Market Segments
-
1.1.2 Anti-PD-1 Antibody Industry Characteristics
-
1.1.3 Global and China Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Anti-PD-1 Antibody Production Value and Growth Rate (2017-2028)
-
1.2 Global Anti-PD-1 Antibody Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Monoclonal
-
1.2.2 Polyclonal
-
1.3 Global Anti-PD-1 Antibody Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 IHC-P
-
1.3.2 ICC/IF
-
1.3.3 WB
-
1.3.4 Flow Cytometry
-
1.3.5 ELISA
-
1.4 Market Analysis by Region
-
1.4.1 North America Anti-PD-1 Antibody Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Anti-PD-1 Antibody Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Anti-PD-1 Antibody Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Anti-PD-1 Antibody Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Anti-PD-1 Antibody Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Anti-PD-1 Antibody Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Anti-PD-1 Antibody Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Anti-PD-1 Antibody Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Anti-PD-1 Antibody Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Anti-PD-1 Antibody Industry Porter's Five Forces Model Analysis
-
2.2.3 Anti-PD-1 Antibody Industry PEST Analysis
-
2.3 Anti-PD-1 Antibody Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Anti-PD-1 Antibody Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Anti-PD-1 Antibody Industry
Chapter 3 Global and China Anti-PD-1 Antibody Market, by Manufacturer
-
3.1 Global and China Anti-PD-1 Antibody Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Anti-PD-1 Antibody Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Anti-PD-1 Antibody Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Anti-PD-1 Antibody Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Anti-PD-1 Antibody Market Top 3 Players
Chapter 4 Global and China Anti-PD-1 Antibody Market, by Type (2017-2028)
-
4.1 Anti-PD-1 Antibody Market Trend, by Type
-
4.2 Global Anti-PD-1 Antibody Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Anti-PD-1 Antibody Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Anti-PD-1 Antibody Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Anti-PD-1 Antibody Price Trend, by Type (2017-2028)
-
4.3 China Anti-PD-1 Antibody Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Anti-PD-1 Antibody Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Anti-PD-1 Antibody Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Anti-PD-1 Antibody Price Trend, by Type (2017-2028)
Chapter 5 Global and China Anti-PD-1 Antibody Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Anti-PD-1 Antibody Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Anti-PD-1 Antibody Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Anti-PD-1 Antibody Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Anti-PD-1 Antibody Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Anti-PD-1 Antibody Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Anti-PD-1 Antibody Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Anti-PD-1 Antibody Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Anti-PD-1 Antibody Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Anti-PD-1 Antibody Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Anti-PD-1 Antibody Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Anti-PD-1 Antibody Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Anti-PD-1 Antibody Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Anti-PD-1 Antibody Market Analysis
-
7.1 North America Anti-PD-1 Antibody Market, by Type
-
7.2 North America Anti-PD-1 Antibody Market, by Application
-
7.3 North America Anti-PD-1 Antibody Market Analysis and Forecast, by Country
-
7.3.1 United States Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Anti-PD-1 Antibody Market Analysis
-
8.1 Europe Anti-PD-1 Antibody Market, by Type
-
8.2 Europe Anti-PD-1 Antibody Market, by Application
-
8.3 Europe Anti-PD-1 Antibody Market Analysis and Forecast, by Country
-
8.3.1 Germany Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Anti-PD-1 Antibody Market Analysis
-
9.1 APAC Anti-PD-1 Antibody Market, by Type
-
9.2 APAC Anti-PD-1 Antibody Market, by Application
-
9.3 APAC Anti-PD-1 Antibody Market Analysis and Forecast, by Country
-
9.3.1 China Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Anti-PD-1 Antibody Market Analysis
-
10.1 Latin America, Middle East and Africa Anti-PD-1 Antibody Market, by Type
-
10.2 Latin America, Middle East and Africa Anti-PD-1 Antibody Market, by Application
-
10.3 Latin America, Middle East and Africa Anti-PD-1 Antibody Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Anti-PD-1 Antibody Company Profiles
-
11.1 3SBio Inc
-
11.1.1 3SBio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 3SBio Inc Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.1.3 3SBio Inc Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Bio X Cell
-
11.2.1 Bio X Cell Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Bio X Cell Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.2.3 Bio X Cell Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Novartis
-
11.3.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Novartis Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.3.3 Novartis Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Thermo Fisher
-
11.4.1 Thermo Fisher Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Thermo Fisher Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.4.3 Thermo Fisher Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Merck
-
11.5.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Merck Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.5.3 Merck Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Abbvie
-
11.6.1 Abbvie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Abbvie Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.6.3 Abbvie Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Abcam
-
11.7.1 Abcam Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Abcam Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.7.3 Abcam Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Lilly
-
11.8.1 Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Lilly Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.8.3 Lilly Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 InvivoGen
-
11.9.1 InvivoGen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 InvivoGen Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.9.3 InvivoGen Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Ono Pharmaceutical Co, Ltd
-
11.10.1 Ono Pharmaceutical Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Ono Pharmaceutical Co, Ltd Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.10.3 Ono Pharmaceutical Co, Ltd Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 BeiGene
-
11.11.1 BeiGene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 BeiGene Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.11.3 BeiGene Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Chugai Pharmaceutical Co, Ltd
-
11.12.1 Chugai Pharmaceutical Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Chugai Pharmaceutical Co, Ltd Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.12.3 Chugai Pharmaceutical Co, Ltd Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Sino Biological Inc
-
11.13.1 Sino Biological Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Sino Biological Inc Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.13.3 Sino Biological Inc Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 BioVision Inc
-
11.14.1 BioVision Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 BioVision Inc Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.14.3 BioVision Inc Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 TG Therapeutics, Inc
-
11.15.1 TG Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 TG Therapeutics, Inc Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.15.3 TG Therapeutics, Inc Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Arcus Biosciences
-
11.16.1 Arcus Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Arcus Biosciences Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.16.3 Arcus Biosciences Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 Bristol-Myers Squibb (BMS)
-
11.17.1 Bristol-Myers Squibb (BMS) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Profiles, Application and Specification
-
11.17.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Anti-PD-1 Antibody Industry Investment Prospect and Risk Assessment
-
12.1 Anti-PD-1 Antibody Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Anti-PD-1 Antibody Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure China Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Global Anti-PD-1 Antibody Production Value and Growth Rate (2017-2028)
-
Figure China Anti-PD-1 Antibody Production Value and Growth Rate (2017-2028)
-
Figure Global Anti-PD-1 Antibody Market Size and Growth Rate of Monoclonal (2017-2028)
-
Figure Global Anti-PD-1 Antibody Market Size and Growth Rate of Polyclonal (2017-2028)
-
Figure Global Anti-PD-1 Antibody Market Size and Growth Rate of IHC-P (2017-2028)
-
Figure Global Anti-PD-1 Antibody Market Size and Growth Rate of ICC/IF (2017-2028)
-
Figure Global Anti-PD-1 Antibody Market Size and Growth Rate of WB (2017-2028)
-
Figure Global Anti-PD-1 Antibody Market Size and Growth Rate of Flow Cytometry (2017-2028)
-
Figure Global Anti-PD-1 Antibody Market Size and Growth Rate of ELISA (2017-2028)
-
Figure North America Anti-PD-1 Antibody Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Anti-PD-1 Antibody Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Anti-PD-1 Antibody Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-PD-1 Antibody Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Anti-PD-1 Antibody Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Anti-PD-1 Antibody Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Anti-PD-1 Antibody Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Anti-PD-1 Antibody Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Anti-PD-1 Antibody Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Anti-PD-1 Antibody Market Share, by Manufacturer in 2021
-
Figure Global and China Anti-PD-1 Antibody Market Share, by Manufacturer in 2022
-
Table Global Anti-PD-1 Antibody Sales Volume, by Type (2017-2028)
-
Table Global Anti-PD-1 Antibody Sales Volume Share, by Type (2017-2028)
-
Figure Global Anti-PD-1 Antibody Sales Volume Share, by Type (2017-2028)
-
Table Global Anti-PD-1 Antibody Sales Value, by Type (2017-2028)
-
Table Global Anti-PD-1 Antibody Sales Value Share, by Type (2017-2028)
-
Figure Global Anti-PD-1 Antibody Price Trend, by Type (2017-2028)
-
Table China Anti-PD-1 Antibody Sales Volume, by Type (2017-2028)
-
Table China Anti-PD-1 Antibody Sales Volume Share, by Type (2017-2028)
-
Figure China Anti-PD-1 Antibody Sales Volume Share, by Type (2017-2028)
-
Table China Anti-PD-1 Antibody Sales Value, by Type (2017-2028)
-
Table China Anti-PD-1 Antibody Sales Value Share, by Type (2017-2028)
-
Figure China Anti-PD-1 Antibody Price Trend, by Type (2017-2028)
-
Table Global Anti-PD-1 Antibody Sales Volume, by Application (2017-2028)
-
Table Global Anti-PD-1 Antibody Sales Volume Share, by Application (2017-2028)
-
Figure Global Anti-PD-1 Antibody Sales Volume Share, by Application (2017-2028)
-
Table Global Anti-PD-1 Antibody Sales Value, by Application (2017-2028)
-
Table Global Anti-PD-1 Antibody Sales Value Share, by Application (2017-2028)
-
Figure Global Anti-PD-1 Antibody Sales Value Share, by Application (2017-2028)
-
Table China Anti-PD-1 Antibody Sales Volume, by Application (2017-2028)
-
Table China Anti-PD-1 Antibody Sales Volume Share, by Application (2017-2028)
-
Figure China Anti-PD-1 Antibody Sales Volume Share, by Application (2017-2028)
-
Table China Anti-PD-1 Antibody Sales Value, by Application (2017-2028)
-
Table China Anti-PD-1 Antibody Sales Value Share, by Application (2017-2028)
-
Figure China Anti-PD-1 Antibody Sales Value Share, by Application (2017-2028)
-
Figure China Anti-PD-1 Antibody Production, Import, Consumption and Export (2017-2022)
-
Figure North America Anti-PD-1 Antibody Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Anti-PD-1 Antibody Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Anti-PD-1 Antibody Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Anti-PD-1 Antibody Production, Import, Consumption and Export (2017-2022)
-
Table North America Anti-PD-1 Antibody Sales Volume, by Type (2017-2028)
-
Table North America Anti-PD-1 Antibody Sales Volume Share, by Type (2017-2028)
-
Figure North America Anti-PD-1 Antibody Sales Volume Share, by Type (2017-2028)
-
Table North America Anti-PD-1 Antibody Sales Volume, by Application (2017-2028)
-
Table North America Anti-PD-1 Antibody Sales Volume Share, by Application (2017-2028)
-
Figure North America Anti-PD-1 Antibody Sales Volume Share, by Application (2017-2028)
-
Figure United States Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure United States Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Canada Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Table Europe Anti-PD-1 Antibody Sales Volume, by Type (2017-2028)
-
Table Europe Anti-PD-1 Antibody Sales Volume Share, by Type (2017-2028)
-
Figure Europe Anti-PD-1 Antibody Sales Volume Share, by Type (2017-2028)
-
Table Europe Anti-PD-1 Antibody Sales Volume, by Application (2017-2028)
-
Table Europe Anti-PD-1 Antibody Sales Volume Share, by Application (2017-2028)
-
Figure Europe Anti-PD-1 Antibody Sales Volume Share, by Application (2017-2028)
-
Figure Germany Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure UK Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure UK Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure France Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure France Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Italy Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Spain Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Poland Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Russia Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Table APAC Anti-PD-1 Antibody Sales Volume, by Type (2017-2028)
-
Table APAC Anti-PD-1 Antibody Sales Volume Share, by Type (2017-2028)
-
Figure APAC Anti-PD-1 Antibody Sales Volume Share, by Type (2017-2028)
-
Table APAC Anti-PD-1 Antibody Sales Volume, by Application (2017-2028)
-
Table APAC Anti-PD-1 Antibody Sales Volume Share, by Application (2017-2028)
-
Figure APAC Anti-PD-1 Antibody Sales Volume Share, by Application (2017-2028)
-
Figure China Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure China Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Japan Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure India Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure India Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Anti-PD-1 Antibody Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Anti-PD-1 Antibody Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-PD-1 Antibody Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Anti-PD-1 Antibody Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Anti-PD-1 Antibody Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-PD-1 Antibody Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Anti-PD-1 Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Anti-PD-1 Antibody Sales Value and Growth Rate (2017-2028)
-
Table 3SBio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table 3SBio Inc Product Profiles, Application and Specification
-
Table 3SBio Inc Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bio X Cell Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bio X Cell Product Profiles, Application and Specification
-
Table Bio X Cell Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Thermo Fisher Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Thermo Fisher Product Profiles, Application and Specification
-
Table Thermo Fisher Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Abbvie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Abbvie Product Profiles, Application and Specification
-
Table Abbvie Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Abcam Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Abcam Product Profiles, Application and Specification
-
Table Abcam Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Lilly Product Profiles, Application and Specification
-
Table Lilly Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table InvivoGen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table InvivoGen Product Profiles, Application and Specification
-
Table InvivoGen Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ono Pharmaceutical Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ono Pharmaceutical Co, Ltd Product Profiles, Application and Specification
-
Table Ono Pharmaceutical Co, Ltd Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BeiGene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BeiGene Product Profiles, Application and Specification
-
Table BeiGene Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Chugai Pharmaceutical Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Chugai Pharmaceutical Co, Ltd Product Profiles, Application and Specification
-
Table Chugai Pharmaceutical Co, Ltd Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sino Biological Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sino Biological Inc Product Profiles, Application and Specification
-
Table Sino Biological Inc Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BioVision Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BioVision Inc Product Profiles, Application and Specification
-
Table BioVision Inc Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table TG Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table TG Therapeutics, Inc Product Profiles, Application and Specification
-
Table TG Therapeutics, Inc Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Arcus Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Arcus Biosciences Product Profiles, Application and Specification
-
Table Arcus Biosciences Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb (BMS) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb (BMS) Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-

Chinese